OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
WALTHAM, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, is pleased to announce changes to its Board of Directors reflecting a strategic move to further align with the company’s growth plans.
Related news for (OPRX)
- OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
- OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
- OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
- OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
- Today’s Top Performers: MoBot’s Market Review 03/12/25 09:00 AM